A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer's disease

A state of delirium: deciphering the effect of inflammation on tau pathology in Alzheimer's disease

Alzheimer's disease (AD), the predominant form of dementia, is highly correlated with the abnormal hyperphosphorylation and aggregation of tau. Immune responses are key drivers of AD and how they contribute to tau pathology in human disease remains largely unknown. This review summarises curren...

Full description

Bibliographic Details
Main Authors:	Barron, Matthew, Gartlon, Jane, Dawson, Lee A., Atkinson, Peter J., Pardon, Marie-Christine
Format:	Article
Language:	English
Published:	Elsevier 2016
Online Access:	http://eprints.nottingham.ac.uk/39894/ http://eprints.nottingham.ac.uk/39894/ http://eprints.nottingham.ac.uk/39894/ http://eprints.nottingham.ac.uk/39894/1/tau%201-s2.0-S0531556516305800-main.pdf

Similar Items

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
by: Lasagna-Reeves, Cristian A., et al.
Published: (2012)

Phospho-Tau and Cognitive Decline in Alzheimer's Disease. Commentary: Tau in physiology and pathology
by: DeFelipe, Javier
Published: (2016)

Structure and Pathology of Tau Protein in Alzheimer Disease
by: Kolarova, Michala, et al.
Published: (2012)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
by: James, Olga G., et al.
Published: (2015)

Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
by: Guo, Jing L., et al.
Published: (2016)

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
by: Kontsekova, Eva, et al.
Published: (2014)

Insulin dysfunction and Tau pathology
by: El Khoury, Noura B., et al.
Published: (2014)

Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
by: Pooler, Amy M, et al.
Published: (2013)

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease
by: Zhang, Zhentao, et al.
Published: (2014)

The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model
by: Li, Tong, et al.
Published: (2016)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
by: Lai, Robert Y. K., et al.
Published: (2016)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
by: Bakota, Lidia, et al.
Published: (2016)

Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer’s-Like Pathological Features in Mice
by: Ghosal, Kaushik, et al.
Published: (2016)

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
by: Kontsekova, Eva, et al.
Published: (2014)

Plasma tau in Alzheimer disease
by: Mattsson, Niklas, et al.
Published: (2016)

Preoperative cerebrospinal fluid β-Amyloid/Tau ratio and postoperative delirium
by: Xie, Zhongcong, et al.
Published: (2014)

Deciphering the role of tau in neurodegeneration using Adeno-Associated Viral (AAV) vectors to express human tau in the mouse forebrain
by: Lathuilière, Aurélien, et al.
Published: (2013)

Tau Protein: Function and Pathology
by: Rosenmann, Hanna, et al.
Published: (2012)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
by: Duka, Valeriy, et al.
Published: (2013)

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo
by: Domise, Manon, et al.
Published: (2016)

Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology*
by: Michel, Claire H., et al.
Published: (2014)

Plasma tau levels in Alzheimer's disease
by: Zetterberg, Henrik, et al.
Published: (2013)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
by: Trojanowski, John Q
Published: (2013)

Ubiquilin 2 Is Not Associated with Tau Pathology
by: Nölle, Anna, et al.
Published: (2013)

Clinical Illustrations of the Pathology and Treatment of Delirium Tremens
Published: (1859)

Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
by: Ozcelik, Sefika, et al.
Published: (2013)

Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody
by: Luo, Wenjie, et al.
Published: (2015)

Neuronal activity enhances tau propagation and tau pathology in vivo
by: Wu, Jessica W., et al.
Published: (2016)

Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
by: S. Gauthier, et al.
Published: (2018-05-01)

Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease
by: Marius Chiasseu, et al.
Published: (2017-08-01)

Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis
by: Harvey, Natasha L, et al.
Published: (2012)

Inflammation biomarkers and delirium in critically ill patients
by: Ritter, Cristiane, et al.
Published: (2014)

Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX-
by: Uchihara, Toshiki, et al.
Published: (2016)

Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation
by: Scholtzova, Henrieta, et al.
Published: (2014)

Impaired burrowing is the most prominent behavioral deficit of aging htau mice
by: Geiszler, Philippine C., et al.
Published: (2016)

Impaired burrowing is the most prominent behavioral deficit of aging htau mice
by: Geiszler, Philippine Camilla, et al.
Published: (2016)

Deciphering cellular states of innate tumor drug responses
by: Graudens, Esther, et al.
Published: (2006)

Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
by: Congdon, Erin E., et al.
Published: (2016)

CSF p-Tau levels in the prediction of Alzheimer's disease
by: Kandimalla, Ramesh J. L., et al.
Published: (2013)

Tau-mediated synaptic damage in Alzheimer’s disease
by: Jadhav Santosh, et al.
Published: (2015-10-01)